Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
7.09
-0.02 (-0.28%)
Apr 29, 2026, 3:04 PM CST

SHE:002550 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
677.5491.05439.95576.23409.26617.81
Short-Term Investments
--192.964.95--
Trading Asset Securities
604.36594.02273.8371.9867.4868.23
Cash & Short-Term Investments
1,2821,085906.67713.16476.73686.03
Cash Growth
52.21%19.68%27.13%49.59%-30.51%-8.58%
Accounts Receivable
244.15299.1274.25275.52632.87447.67
Other Receivables
18.6918.9423.2416.92.482.56
Receivables
262.84318.04297.48292.42635.35450.23
Inventory
403.97372.44426.81602.01536.48400.63
Prepaid Expenses
-----0.01
Other Current Assets
80.05134.1862.7318.3938.7233.04
Total Current Assets
2,0291,9101,6941,6261,6871,570
Property, Plant & Equipment
694.22681.93563.6561.27616.39611.77
Long-Term Investments
132.97134.16160.08203.22156.7840.56
Goodwill
11.1411.1411.1411.1411.1411.14
Other Intangible Assets
106.39107.21109.32113.14100.86106.92
Long-Term Deferred Tax Assets
66.3566.5275.2690.53101.4999.42
Long-Term Deferred Charges
183.09173.03138.0493.7760.3346.85
Other Long-Term Assets
8.994.4715.33.0571.6721.81
Total Assets
3,2323,0882,8302,7662,8062,508
Accounts Payable
94.5578.8288.6441.1845.9771.23
Accrued Expenses
16.5938.6588.0689.7101.9499.55
Short-Term Debt
--21.4956.31103.0593.56
Current Income Taxes Payable
20.117.81.530.640.05-
Current Unearned Revenue
6.217.649.689.7115.5819.67
Other Current Liabilities
140.692.61148.2811.6312.34
Total Current Liabilities
278.06225.52223.39205.81278.22296.35
Long-Term Leases
3.13.07----
Long-Term Unearned Revenue
93.9488.5886.4681.8589.3593.42
Long-Term Deferred Tax Liabilities
4.724.784.024.524.960.47
Total Liabilities
379.82321.95313.87292.17372.53390.24
Common Stock
1,2801,2801,2801,2801,2801,280
Additional Paid-In Capital
30.2141.4241.6541.6536.2929.38
Retained Earnings
1,7031,6181,3691,1631,134960.89
Treasury Stock
-156.88-170.86-170.86-30.09--145.05
Comprehensive Income & Other
-1.99-0.55-2.420.36-0.062.23
Total Common Equity
2,8542,7682,5172,4552,4502,127
Minority Interest
-2.24-1.68-0.8718.98-16.95-9.09
Shareholders' Equity
2,8522,7662,5172,4742,4332,118
Total Liabilities & Equity
3,2323,0882,8302,7662,8062,508
Total Debt
3.13.0721.4956.31103.0593.56
Net Cash (Debt)
1,2791,082885.19656.85373.69592.48
Net Cash Growth
55.54%22.23%34.76%75.78%-36.93%-16.38%
Net Cash Per Share
1.030.870.700.510.290.49
Filing Date Shares Outstanding
1,2541,2351,2501,2751,2801,280
Total Common Shares Outstanding
1,2541,2351,2501,2751,2801,280
Working Capital
1,7511,6841,4701,4201,4091,274
Book Value Per Share
2.282.242.011.931.911.66
Tangible Book Value
2,7372,6502,3972,3312,3382,009
Tangible Book Value Per Share
2.182.151.921.831.831.57
Buildings
--498.75498.75525.73524.28
Machinery
--568.44558.3504.84461.29
Construction In Progress
--61.258.1954.139.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.